Incannex Healthcare Inc. (IXHL), a clinical-stage biopharmaceutical company, on Friday announced that its board has approved a share repurchase program of up to $20 million of its outstanding common stock.
The company said buybacks may be executed through open-market purchases, privately negotiated transactions, accelerated share repurchase arrangements.
The program reflects the company's commitment to driving sustainable shareholder value while maintaining disciplined capital allocation to support the advancement of its late-stage clinical pipeline.
In the pre-market trading, Incannex Healthcare is 31.6066% higher at $0.6021 on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.